FULC: fulcrumtx.com Expected earnings per share growth for next year

Public company logo of Fulcrum Therapeutics (FULC)

Capital shortage risks and the volatility of blood disease drug trials are driving the current trend. The historical n+1 profit forecast trend on the GURU.Markets chart confirms this dynamics, where 79.20 reflects the latest metric value. The prospects for Fulcrum Therapeutics (FULC) depend on the efficacy of losmapimod and FDA approval, as the company strives to outperform peers in the development of drugs for genetic pathologies.

Fulcrum Therapeutics Inc (FULC): Net earnings per share change forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Fulcrum Therapeutics Inc (FULC)

- share price and consensus valuation forecast:
Fundamental company valuation:FULC, fulcrumtx.com
Finished products of Fulcrum Therapeutics, Inc.

Analyzing changes in analyst EPS growth estimates allows for an assessment of Fulcrum Therapeutics (FULC) as a biopharmaceutical innovator. This indicator reflects the daily consensus forecast for next year's profit dynamics, filtering out market noise. The metric is sensitive to advancements in robotic drug synthesis and AI-driven gene expression modeling. The steady trend on this chart confirms market confidence in clinical trial efficacy and long-term capital stability.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year